(1)
Strober, B.; Krueger, J.; Magnolo, N.; Vender, R.; Toth, D.; Thaci, D.; Wang, M.; Cioffi, C.; Madden, C.; Warren, R. Bimekizumab Versus Ustekinumab Efficacy Across Subgroups of Patients With Moderate to Severe Plaque Psoriasis: Results from the Multicenter, Randomized, Double-Blinded Phase 3 BE VIVID Trial. J of Skin 2021, 5, s16.